Q4 2022 Aquestive Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. (Operator Instructions) As a reminder, this call is being recorded.
I will now turn the call over to your host for today's conference call, Bennett Watson of Westwicke Investor Relations. You may begin.
Thank you operator. Good morning and welcome to today's call. On today's call, I'm joined by Dan Barber, Chief Executive Officer; and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business development and performance for the fourth quarter of 2022 followed by a Q&A session. During the Q&A session, the team will be joined by Steve Wargacki, Vice President of R&D and Ken Marshall, Chief Commercial Officer.
As a reminder, the company's remarks today correspond with their earnings release that was issued after market closed yesterday. In addition, a recording of today's call will be made available on Aquestive's website within the investor section shortly following the conclusion of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |